Nanoarchitectured Bioconjugates and Bioreceptors Mediated Surface Plasmon Resonance Biosensor for In Vitro Diagnosis of Alzheimer’s Disease: Development and Future Prospects

References

• Baranowska-Wójcik, E.; Szwajgier, D. Alzheimer’s Disease: Review of Current Nanotechnological Therapeutic Strategies. Expert Rev. Neurother. 2020, 20, 271–279. DOI: 10.1080/14737175.2020.1719069.
   PubMed Web of Science ®Google Scholar
• Ryan, N. S.; Rossor, M. N.; Fox, N. C. Alzheimer's Disease in the 100 Years Since Alzheimer’s Death. Brain 2015, 138, 3816–3821. DOI: 10.1093/brain/awv316.
   PubMed Web of Science ®Google Scholar
• Hippius, H.; Neundörfer, G. The Discovery of Alzheimer's Disease. Dialogues Clin. Neurosci. 2003, 5, 101–108.
   PubMedGoogle Scholar
• Anand, R.; Gill, K. D.; Mahdi, A. A. Therapeutics of Alzheimer's Disease: Past, Present and Future. Neuropharmacology 2014, 76, 27–50. DOI: 10.1016/j.neuropharm.2013.07.004.
   PubMed Web of Science ®Google Scholar
• Alzheimer’s Association. 2018 Alzheimer's Disease Facts and Figures. Alzheimers Dement. 2018, 14, 367–429.
   Web of Science ®Google Scholar
• World Health Organization. Neurological Disorders Public Health Challenges. WHO Library Cataloguing-in-Publication Data 2006.
   Google Scholar
• Alzheimer’s Association. 2020 Alzheimer's Disease Facts and Figures. Alzheimers Dement. 2020, 16, 391–460.
   Web of Science ®Google Scholar
• Thies, W.; Bleiler, L.; Alzheimer’s Association. Alzheimer’s Disease Facts and Figures. Alzheimers Dement 2013, 9, 208e245. DOI: 10.1016/j.jalz.2013.02.003.
   Google Scholar
• Santana, I.; Farinha, F.; Freitas, S.; Rodrigues, V.; Carvalho, Á. The Epidemiology of Dementia and Alzheimer Disease in Portugal: estimations of Prevalence and Treatment-Costs. Acta Med. Port. 2015, 28, 182–188. DOI: 10.20344/amp.6025.
   PubMed Web of Science ®Google Scholar
• Posar, A.; Resca, F.; Visconti, P. Autism according to Diagnostic and Statistical Manual of Mental Disorders 5(th) edition: The Need for Further Improvements. J. Pediatr. Neurosci. 2015, 10, 146–148. DOI: 10.4103/1817-1745.159195.
   PubMed Web of Science ®Google Scholar
• Indu Bhushan, M. K.; Kour, G.; Gupta, S.; Sharma, S.; Yadav, A. Alzheimer’s Disease: Causes and Treatment – A Review. Ann. Biotechnol 2018, 2018, 1002.
   Google Scholar
• Povova, J.; Ambroz, P.; Bar, M.; Pavukova, V.; Sery, O.; Tomaskova, H.; Janout, V. Epidemiological of and Risk Factors for Alzheimer's Disease: A Review. Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc. Czech. Repub. 2012, 156, 108–114. DOI: 10.5507/bp.2012.055.
   PubMed Web of Science ®Google Scholar
• Croft, P.; Altman, D. G.; Deeks, J. J.; Dunn, K. M.; Hay, A. D.; Hemingway, H.; LeResche, L.; Peat, G.; Perel, P.; Petersen, S. E.; et al. The Science of Clinical Practice: disease Diagnosis or Patient Prognosis? Evidence about “What Is Likely to Happen” Should Shape Clinical Practice. BMC Med. 2015, 13, 20–28. DOI: 10.1186/s12916-014-0265-4.
   PubMed Web of Science ®Google Scholar
• Prince, M.; Bryce, R.; Albanese, E.; Wimo, A.; Ribeiro, W.; Ferri, C. P. The Global Prevalence of Dementia: A Systematic Review and Metaanalysis. Alzheimers. Dement. 2013, 9, 63–75. e2. DOI: 10.1016/j.jalz.2012.11.007.
   PubMed Web of Science ®Google Scholar
• Wei, T.-Y.; Fu, Y.; Chang, K.-H.; Lin, K.-J.; Lu, Y.-J.; Cheng, C.-M. Point-of-Care Devices Using Disease Biomarkers to Diagnose Neurodegenerative Disorders. Trends Biotechnol. 2018, 36, 290–303. DOI: 10.1016/j.tibtech.2017.11.004.
   PubMed Web of Science ®Google Scholar
• Carneiro, P.; Morais, S.; Pereira, M. C. Nanomaterials towards Biosensing of Alzheimer’s Disease Biomarkers. Nanomaterials 2019, 9, 1663. DOI: 10.3390/nano9121663.
   Web of Science ®Google Scholar
• Nikhil, B.; Pawan, J.; Nello, F.; Pedro, E. Introduction to Biosensors. Essays in Biochemistry 2016, 60, 1–8.
   PubMed Web of Science ®Google Scholar
• Malhotra, B. D.; Ali, M. A. Nanomaterials for Biosensors: Fundamentals and Applications. New York, NY: Elsevier, 2018.
   Google Scholar
• Patil, P. O.; Pandey, G. R.; Patil, A. G.; Borse, V. B.; Deshmukh, P. K.; Patil, D. R.; Tade, R. S.; Nangare, S. N.; Khan, Z. G.; Patil, A. M.; et al. Graphene-Based Nanocomposites for Sensitivity Enhancement of Surface Plasmon Resonance Sensor for Biological and Chemical Sensing: A Review. Biosens. Bioelectron. 2019, 139, 111324 DOI: 10.1016/j.bios.2019.111324.
   PubMed Web of Science ®Google Scholar
• Zhang, J.; Sun, Y.; Wu, Q.; Gao, Y.; Zhang, H.; Bai, Y.; Song, D. Preparation of Graphene Oxide-Based Surface Plasmon Resonance Biosensor with Au Bipyramid Nanoparticles as Sensitivity Enhancer. Colloids Surf. B. Biointerfaces 2014, 116, 211–218. DOI: 10.1016/j.colsurfb.2014.01.003.
   PubMed Web of Science ®Google Scholar
• Homola, J.; Yee, S. S.; Gauglitz, G. Surface Plasmon Resonance Sensors. Sens. Actuators, B. 1999, 54, 3–15. DOI: 10.1016/S0925-4005(98)00321-9.
   Web of Science ®Google Scholar
• Antiochia, R.; Bollella, P.; Favero, G.; Mazzei, F. Nanotechnology-Based Surface Plasmon Resonance Affinity Biosensors for in Vitro Diagnostics. Int. J. Anal. Chem. 2016, 2016, 2981931. DOI: 10.1155/2016/2981931.
   PubMed Web of Science ®Google Scholar
• Zhang, L.; Mazouzi, Y.; Salmain, M.; Liedberg, B.; Boujday, S. Antibody-Gold Nanoparticle Bioconjugates for Biosensors: Synthesis, Characterization and Selected Applications. Biosens. Bioelectron. 2020, 165, 112370. DOI: 10.1016/j.bios.2020.112370.
   PubMed Web of Science ®Google Scholar
• Chintamaneni, M.; Bhaskar, M. Biomarkers in Alzheimer's Disease: A Review. ISRN Pharmacol 2012, 2012, 984786. DOI: 10.5402/2012/984786.
   PubMedGoogle Scholar
• Villemagne, V. L.; Burnham, S.; Bourgeat, P.; Brown, B.; Ellis, K. A.; Salvado, O.; Szoeke, C.; Macaulay, S. L.; Martins, R.; Maruff, P.; et al. Amyloid β Deposition, Neurodegeneration, and Cognitive Decline in Sporadic Alzheimer's Disease: A Prospective Cohort Study. Lancet. Neurol. 2013, 12, 357–367. DOI: 10.1016/S1474-4422(13)70044-9.
   PubMed Web of Science ®Google Scholar
• Humpel, C.; Hochstrasser, T. Cerebrospinal Fluid and Blood Biomarkers in Alzheimer's disease. World J. Psychiatry 2011, 1, 8–18. DOI: 10.5498/wjp.v1.i1.8.
   PubMedGoogle Scholar
• Brazaca, L. C.; Sampaio, I.; Zucolotto, V.; Janegitz, B. C. Applications of Biosensors in Alzheimer's Disease Diagnosis. Talanta 2020, 210, 120644. DOI: 10.1016/j.talanta.2019.120644.
   PubMed Web of Science ®Google Scholar
• Tang, B. L.; Kumar, R. Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease. Ann. Acad. Med. Singapore 2008, 37, 406–415.
   PubMed Web of Science ®Google Scholar
• Mattsson, N.; Zetterberg, H. Alzheimer’s Disease and CSF Biomarkers: Key Challenges for Broad Clinical Applications. Biomark. Med. 2009, 3, 735–737. DOI: 10.2217/bmm.09.65.
   PubMed Web of Science ®Google Scholar
• Visser, P. J.; Verhey, F.; Knol, D. L.; Scheltens, P.; Wahlund, L.-O.; Freund-Levi, Y.; Tsolaki, M.; Minthon, L.; Wallin, A. K.; Hampel, H.; et al. Prevalence and Prognostic Value of CSF Markers of Alzheimer's Disease Pathology in Patients with Subjective Cognitive Impairment or Mild Cognitive Impairment in the DESCRIPA Study: A Prospective Cohort Study. Lancet. Neurol. 2009, 8, 619–627. DOI: 10.1016/S1474-4422(09)70139-5.
   PubMed Web of Science ®Google Scholar
• Hampel, H.; Frank, R.; Broich, K.; Teipel, S. J.; Katz, R. G.; Hardy, J.; Herholz, K.; Bokde, A. L. W.; Jessen, F.; Hoessler, Y. C.; et al. Biomarkers for Alzheimer's Disease: academic, Industry and Regulatory Perspectives. Nat. Rev. Drug Discov. 2010, 9, 560–574. DOI: 10.1038/nrd3115.
   PubMed Web of Science ®Google Scholar
• Blennow, K.; Hampel, H.; Weiner, M.; Zetterberg, H. Cerebrospinal Fluid and Plasma Biomarkers in Alzheimer Disease. Nat. Rev. Neurol. 2010, 6, 131–144. DOI: 10.1038/nrneurol.2010.4.
   PubMed Web of Science ®Google Scholar
• Shui, B.; Tao, D.; Florea, A.; Cheng, J.; Zhao, Q.; Gu, Y.; Li, W.; Jaffrezic-Renault, N.; Mei, Y.; Guo, Z. Biosensors for Alzheimer's Disease Biomarker Detection: A Review. Biochimie 2018, 147, 13–24. DOI: 10.1016/j.biochi.2017.12.015.
   PubMed Web of Science ®Google Scholar
• Kaushik, A.; Jayant, R. D.; Tiwari, S.; Vashist, A.; Nair, M. Nano-Biosensors to Detect Beta-Amyloid for Alzheimer's Disease Management. Biosens. Bioelectron. 2016, 80, 273–287. DOI: 10.1016/j.bios.2016.01.065.
   PubMed Web of Science ®Google Scholar
• Prabhulkar, S.; Piatyszek, R.; Cirrito, J. R.; Wu, Z. Z.; Li, C. Z. Microbiosensor for Alzheimer’s Disease Diagnostics: Detection of Amyloid Beta Biomarkers. J. Neurochem. 2012, 122, 374–381. DOI: 10.1111/j.1471-4159.2012.07709.x.
   PubMed Web of Science ®Google Scholar
• Neely, A.; Perry, C.; Varisli, B.; Singh, A. K.; Arbneshi, T.; Senapati, D.; Kalluri, J. R.; Ray, P. C. Ultrasensitive and Highly Selective Detection of Alzheimer’s Disease Biomarker using Two-Photon Rayleigh Scattering Properties of Gold Nanoparticle. ACS Nano. 2009, 3, 2834–2840. DOI: 10.1021/nn900813b.
   PubMed Web of Science ®Google Scholar
• Bertram, L.; Lill, C. M.; Tanzi, R. E. The Genetics of Alzheimer Disease: Back to the Future. Neuron 2010, 68, 270–281. DOI: 10.1016/j.neuron.2010.10.013.
   PubMed Web of Science ®Google Scholar
• Lanoiselée, H.-M.; Nicolas, G.; Wallon, D.; Rovelet-Lecrux, A.; Lacour, M.; Rousseau, S.; Richard, A.-C.; Pasquier, F.; Rollin-Sillaire, A.; Martinaud, O.; et al. APP, PSEN1, and PSEN2 Mutations in Early-Onset Alzheimer Disease: A Genetic Screening Study of Familial and Sporadic Cases. PLoS Med. 2017, 14, e1002270. DOI: 10.1371/journal.pmed.1002270.
   PubMed Web of Science ®Google Scholar
• Huynh, R. A.; Mohan, C. Alzheimer's Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid. Front. Neurol. 2017, 8, 102. DOI: 10.3389/fneur.2017.00102.
   PubMed Web of Science ®Google Scholar
• Ma, Q.-L.; Teng, E.; Zuo, X.; Jones, M.; Teter, B.; Zhao, E. Y.; Zhu, C.; Bilousova, T.; Gylys, K. H.; Apostolova, L. G.; et al. Neuronal Pentraxin 1: A Synaptic-Derived Plasma Biomarker in Alzheimer’s Disease. Neurobiol. Dis. 2018, 114, 120–128. DOI: 10.1016/j.nbd.2018.02.014.
   PubMed Web of Science ®Google Scholar
• Kelleher, R. J.; Shen, J. Presenilin-1 Mutations and Alzheimer’s Disease. Proc. Natl. Acad. Sci. U. S. A. 2017, 114, 629–631. DOI: 10.1073/pnas.1619574114.
   PubMed Web of Science ®Google Scholar
• Kehoe, E. G.; McNulty, J. P.; Mullins, P. G.; Bokde, A. L. Advances in MRI Biomarkers for the Diagnosis of Alzheimer's Disease. Biomark. Med. 2014, 8, 1151–1169. DOI: 10.2217/bmm.14.42.
   PubMed Web of Science ®Google Scholar
• Khoury, R.; Ghossoub, E. Diagnostic Biomarkers of Alzheimer’s Disease: A State-of-the-Art Review. Biomarkers in Neuropsychiatry 2019, 1, 100005. DOI: 10.1016/j.bionps.2019.100005.
   Google Scholar
• Golebiowski, M.; Barcikowska, M.; Pfeffer, A. Magnetic Resonance Imaging-Based Hippocampal Volumetry in Patients with Dementia of the Alzheimer Type. Dement. Geriatr. Cogn. Disord. 1999, 10, 284–288. DOI: 10.1159/000017133.
   PubMed Web of Science ®Google Scholar
• Bloudek, L. M.; Spackman, D. E.; Blankenburg, M.; Sullivan, S. D. Review and Meta-Analysis of Biomarkers and Diagnostic Imaging in Alzheimer's Disease. J. Alzheimers. Dis. 2011, 26, 627–645. DOI: 10.3233/JAD-2011-110458.
   PubMed Web of Science ®Google Scholar
• Trzepacz, P. T.; Yu, P.; Sun, J.; Schuh, K.; Case, M.; Witte, M. M.; Hochstetler, H.; Hake, A.; Alzheimer's Disease Neuroimaging Initiative. Comparison of Neuroimaging Modalities for the Prediction of Conversion from Mild Cognitive Impairment to Alzheimer's Dementia. Neurobiol. Aging. 2014, 35, 143–151. DOI: 10.1016/j.neurobiolaging.2013.06.018.
   PubMed Web of Science ®Google Scholar
• Aisen, P. S.; Petersen, R. C.; Donohue, M. C.; Gamst, A.; Raman, R.; Thomas, R. G.; Walter, S.; Trojanowski, J. Q.; Shaw, L. M.; Beckett, L. A.; Alzheimer's Disease Neuroimaging Initiative; et al. Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: Progress and Plans. Alzheimers. Dement. 2010, 6, 239–246. DOI: 10.1016/j.jalz.2010.03.006.
   PubMed Web of Science ®Google Scholar
• Ou, Y.-N.; Xu, W.; Li, J.-Q.; Guo, Y.; Cui, M.; Chen, K.-L.; Huang, Y.-Y.; Dong, Q.; Tan, L.; Yu, J.-T.; On behalf of Alzheimer’s Disease Neuroimaging Initiative. FDG-PET as an Independent Biomarker for Alzheimer’s Biological Diagnosis: A Longitudinal Study. Alz. Res. Therapy 2019, 11, 57. DOI: 10.1186/s13195-019-0512-1.
   PubMed Web of Science ®Google Scholar
• Anchisi, D.; Borroni, B.; Franceschi, M.; Kerrouche, N.; Kalbe, E.; Beuthien-Beumann, B.; Cappa, S.; Lenz, O.; Ludecke, S.; Marcone, A.; et al. Heterogeneity of Brain Glucose Metabolism in Mild Cognitive Impairment and Clinical Progression to Alzheimer Disease. Arch. Neurol. 2005, 62, 1728–1733. DOI: 10.1001/archneur.62.11.1728.
   PubMedGoogle Scholar
• Yuan, Y.; Gu, Z.-X.; Wei, W.-S. Fluorodeoxyglucose–Positron-Emission Tomography, Single-Photon Emission Tomography, and Structural MR Imaging for Prediction of Rapid Conversion to Alzheimer Disease in Patients with Mild Cognitive Impairment: A Meta-Analysis. AJNR Am. J. Neuroradiol. 2009, 30, 404–410. DOI: 10.3174/ajnr.A1357.
   PubMed Web of Science ®Google Scholar
• Marcus, C.; Mena, E.; Subramaniam, R. M. Brain PET in the Diagnosis of Alzheimer’s Disease. Clin. Nucl. Med. 2014, 39, e413.
   PubMed Web of Science ®Google Scholar
• Zhang, S.; Smailagic, N.; Hyde, C.; Noel‐Storr, A. H.; Takwoingi, Y.; McShane, R.; Feng, J. 11C‐PIB‐PET for the Early Diagnosis of Alzheimer’s Disease Dementia and Other Dementias in People with Mild Cognitive Impairment (MCI). Cochrane Database Syst. Rev. 2014, 2014, CD010386.
   PubMedGoogle Scholar
• O’Brien, J. T.; Herholz, K. Amyloid Imaging for Dementia in Clinical Practice. BMC Med. 2015, 13, 1–3. DOI: 10.1186/s12916-015-0404-6.
   PubMed Web of Science ®Google Scholar
• Martínez, G.; Vernooij, R. W.; Padilla, P. F.; Zamora, J.; Cosp, X. B.; Flicker, L. 18F PET with Florbetapir for the Early Diagnosis of Alzheimer’s Disease Dementia and Other Dementias in People with Mild Cognitive Impairment (MCI). Cochrane Database Syst. Rev. 2017, 11, CD012216.
   PubMedGoogle Scholar
• Martínez, G.; Vernooij, R. W.; Padilla, P. F.; Zamora, J.; Flicker, L.; Cosp, X. B. 18F PET with Florbetaben for the Early Diagnosis of Alzheimer's Disease Dementia and Other Dementias in People with Mild Cognitive Impairment (MCI). Cochrane Database of Systematic Reviews 2017, 11, CD012884.
   PubMedGoogle Scholar
• Müller, E. G.; Edwin, T. H.; Stokke, C.; Navelsaker, S. S.; Babovic, A.; Bogdanovic, N.; Knapskog, A. B.; Revheim, M. E. Amyloid-β PET-Correlation with Cerebrospinal Fluid Biomarkers and Prediction of Alzheimer’s Disease Diagnosis in a Memory Clinic. PloS One 2019, 14, e0221365. DOI: 10.1371/journal.pone.0221365.
   PubMed Web of Science ®Google Scholar
• Ferreira, D.; Perestelo-Prez, L.; Westman, E.; Wahlund, L.; Sarra, A.; Serrano-Aguilar, P. Meta-Review of CSF Core Biomarkers in Alzheimer’s Disease: The State-of-the-Art after the New Revised Diagnostic Criteria. Front Aging Neurosci 2014, 6, 1–24.
   PubMed Web of Science ®Google Scholar
• Folch, J.; Petrov, D.; Ettcheto, M.; Abad, S.; Sánchez-López, E.; García, M. L.; Olloquequi, J.; Beas-Zarate, C.; Auladell, C.; Camins, A. Current Research Therapeutic Strategies for Alzheimer’s Disease Treatment. Neural Plast. 2016, 2016, 8501693. DOI: 10.1155/2016/8501693.
   PubMed Web of Science ®Google Scholar
• Zvěřová, M. Alzheimer’s Disease and Blood-Based Biomarkers – Potential Contexts of Use. Neuropsychiatr. Dis. Treat. 2018, 14, 1877–1882. DOI: 10.2147/NDT.S172285.
   PubMed Web of Science ®Google Scholar
• O'Bryant, S. E.; Mielke, M. M.; Rissman, R. A.; Lista, S.; Vanderstichele, H.; Zetterberg, H.; Lewczuk, P.; Posner, H.; Hall, J.; Johnson, L.; Biofluid Based Biomarker Professional Interest Area; et al. Blood-Based Biomarkers in Alzheimer Disease: current State of the Science and a Novel Collaborative Paradigm for Advancing from Discovery to Clinic. Alzheimers. Dement. 2017, 13, 45–58. DOI: 10.1016/j.jalz.2016.09.014.
   PubMed Web of Science ®Google Scholar
• Pláteník, J.; Fišar, Z.; Buchal, R.; Jirák, R.; Kitzlerová, E.; Zvěřová, M.; Raboch, J. GSK3β, CREB, and BDNF in Peripheral Blood of Patients with Alzheimer's Disease and Depression. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2014, 50, 83–93. DOI: 10.1016/j.pnpbp.2013.12.001.
   PubMed Web of Science ®Google Scholar
• Fiandaca, M. S.; Zhong, X.; Cheema, A. K.; Orquiza, M. H.; Chidambaram, S.; Tan, M. T.; Gresenz, C. R.; FitzGerald, K. T.; Nalls, M. A.; Singleton, A. B.; et al. Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer’s Disease. Front. Neurol. 2015, 6, 237. DOI: 10.3389/fneur.2015.00237.
   PubMed Web of Science ®Google Scholar
• Voyle, N.; Baker, D.; Burnham, S. C.; Covin, A.; Zhang, Z.; Sangurdekar, D. P.; Tan Hehir, C. A.; Bazenet, C.; Lovestone, S.; Kiddle, S.; Dobson, R. J. B.; AIBL Research Group. Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology. J. Alzheimers. Dis. 2015, 46, 947–961. DOI: 10.3233/JAD-150020.
   PubMed Web of Science ®Google Scholar
• Panegyres, P. K.; Chen, H.-Y. Differences between Early and Late Onset Alzheimer’s Disease. American Journal of Neurodegenerative Disease 2013, 2, 300.
   PubMedGoogle Scholar
• Nicolas, G.; Wallon, D.; Charbonnier, C.; Quenez, O.; Rousseau, S.; Richard, A.-C.; Rovelet-Lecrux, A.; Coutant, S.; Le Guennec, K.; Bacq, D.; et al. Screening of Dementia Genes by Whole-Exome Sequencing in Early-Onset Alzheimer Disease: input and Lessons. Eur. J. Hum. Genet. 2016, 24, 710–716. DOI: 10.1038/ejhg.2015.173.
   PubMed Web of Science ®Google Scholar
• Mattsson, N.; Andreasson, U.; Zetterberg, H.; Blennow, K.; for the Alzheimer’s Disease Neuroimaging Initiative Association of Plasma Neurofilament Light with Neurodegeneration in Patients with Alzheimer Disease. JAMA Neurol. 2017, 74, 557–566. DOI: 10.1001/jamaneurol.2016.6117.
   PubMed Web of Science ®Google Scholar
• Mattsson, N.; Zetterberg, H.; Janelidze, S.; Insel, P. S.; Andreasson, U.; Stomrud, E.; Palmqvist, S.; Baker, D.; Tan Hehir, C. A.; Jeromin, A.; ADNI Investigators; et al. Plasma Tau in Alzheimer Disease. Neurology 2016, 87, 1827–1835. DOI: 10.1212/WNL.0000000000003246.
   PubMed Web of Science ®Google Scholar
• Kuhle, J.; Barro, C.; Andreasson, U.; Derfuss, T.; Lindberg, R.; Sandelius, Å.; Liman, V.; Norgren, N.; Blennow, K.; Zetterberg, H. Comparison of Three Analytical Platforms for Quantification of the Neurofilament Light Chain in Blood Samples: ELISA, Electrochemiluminescence Immunoassay and Simoa. Clin. Chem. Lab. Med. (CCLM) 2016, 54, 1655–1661. DOI: 10.1515/cclm-2015-1195.
   Google Scholar
• Gisslén, M.; Price, R. W.; Andreasson, U.; Norgren, N.; Nilsson, S.; Hagberg, L.; Fuchs, D.; Spudich, S.; Blennow, K.; Zetterberg, H. Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study. EBioMedicine 2016, 3, 135–140. DOI: 10.1016/j.ebiom.2015.11.036.
   PubMed Web of Science ®Google Scholar
• Blennow, K.; Zetterberg, H. Biomarkers for Alzheimer's Disease: Current Status and Prospects for the Future. J. Intern. Med. 2018, 284, 643–663. DOI: 10.1111/joim.12816.
   PubMed Web of Science ®Google Scholar
• Humpel, C. Identifying and Validating Biomarkers for Alzheimer's Disease. Trends Biotechnol. 2011, 29, 26–32. DOI: 10.1016/j.tibtech.2010.09.007.
   PubMed Web of Science ®Google Scholar
• Hu, W. T.; Holtzman, D. M.; Fagan, A. M.; Shaw, L. M.; Perrin, R.; Arnold, S. E.; Grossman, M.; Xiong, C.; Craig-Schapiro, R.; Clark, C. M.; Alzheimer's Disease Neuroimaging Initiative; et al. Plasma Multianalyte Profiling in Mild Cognitive Impairment and Alzheimer Disease. Neurology 2012, 79, 897–905. DOI: 10.1212/WNL.0b013e318266fa70.
   PubMed Web of Science ®Google Scholar
• Ashton, N. J.; Ide, M.; Zetterberg, H.; Blennow, K. Salivary Biomarkers for Alzheimer's Disease and Related Disorders. Neurol. Ther. 2019, 8, 83–94. DOI: 10.1007/s40120-019-00168-1.
   PubMed Web of Science ®Google Scholar
• Zhang, Y.; Sun, J.; Lin, C. C.; Abemayor, E.; Wang, M. B.; Wong, D. T. The Emerging Landscape of Salivary Diagnostics. Periodontol 2000. 2016, 70, 38–52. DOI: 10.1111/prd.12099.
   PubMed Web of Science ®Google Scholar
• Farah, R.; Haraty, H.; Salame, Z.; Fares, Y.; Ojcius, D. M.; Sadier, N. S. Salivary Biomarkers for the Diagnosis and Monitoring of Neurological Diseases. Biomed. J. 2018, 41, 63–87. DOI: 10.1016/j.bj.2018.03.004.
   PubMed Web of Science ®Google Scholar
• Jasim, H.; Carlsson, A.; Hedenberg-Magnusson, B.; Ghafouri, B.; Ernberg, M. Saliva as a Medium to Detect and Measure Biomarkers Related to Pain. Sci. Rep. 2018, 8, 1–9. DOI: 10.1038/s41598-018-21131-4.
   PubMed Web of Science ®Google Scholar
• Gleerup, H. S.; Hasselbalch, S. G.; Simonsen, A. H. Biomarkers for Alzheimer’s Disease in Saliva: A Systematic Review. Dis Markers 2019, 2019, 4761054. DOI: 10.1155/2019/4761054.
   PubMed Web of Science ®Google Scholar
• Masson, J.-F. Surface Plasmon Resonance Clinical Biosensors for Medical Diagnostics. ACS Sens. 2017, 2, 16–30. DOI: 10.1021/acssensors.6b00763.
   PubMed Web of Science ®Google Scholar
• Oeckl, P.; Otto, M. A Review on MS-Based Blood Biomarkers for Alzheimer's Disease. Neurol. Ther. 2019, 8, 113–127. DOI: 10.1007/s40120-019-00165-4.
   PubMed Web of Science ®Google Scholar
• Crutchfield, C. A.; Thomas, S. N.; Sokoll, L. J.; Chan, D. W. Advances in Mass Spectrometry-Based Clinical Biomarker Discovery. Clin. Proteomics. 2016, 13, 1–12. DOI: 10.1186/s12014-015-9102-9.
   PubMed Web of Science ®Google Scholar
• Nakamura, A.; Kaneko, N.; Villemagne, V. L.; Kato, T.; Doecke, J.; Doré, V.; Fowler, C.; Li, Q.-X.; Martins, R.; Rowe, C.; et al. High Performance Plasma Amyloid-β Biomarkers for Alzheimer’s Disease. Nature 2018, 554, 249–254. DOI: 10.1038/nature25456.
   PubMed Web of Science ®Google Scholar
• Liu, Y.; Qing, H.; Deng, Y. Biomarkers in Alzheimer’s Disease Analysis by Mass Spectrometry-Based Proteomics. Int. J. Mol. Sci. 2014, 15, 7865–7882. DOI: 10.3390/ijms15057865.
   PubMed Web of Science ®Google Scholar
• McAvoy, T.; Lassman, M. E.; Spellman, D. S.; Ke, Z.; Howell, B. J.; Wong, O.; Zhu, L.; Tanen, M.; Struyk, A.; Laterza, O. F. Quantification of Tau in Cerebrospinal Fluid by Immunoaffinity Enrichment and Tandem Mass Spectrometry. Clin. Chem. 2014, 60, 683–689. DOI: 10.1373/clinchem.2013.216515.
   PubMed Web of Science ®Google Scholar
• Yang, T.; Hong, S.; O'Malley, T.; Sperling, R. A.; Walsh, D. M.; Selkoe, D. J. New ELISAs with High Specificity for Soluble Oligomers of Amyloid β-Protein Detect Natural Aβ Oligomers in Human Brain but Not CSF. Alzheimers. Dement. 2013, 9, 99–112. DOI: 10.1016/j.jalz.2012.11.005.
   PubMed Web of Science ®Google Scholar
• Kang, J.-H.; Korecka, M.; Toledo, J. B.; Trojanowski, J. Q.; Shaw, L. M. Clinical Utility and Analytical Challenges in Measurement of Cerebrospinal Fluid Amyloid-β(1-42) and τ Proteins as Alzheimer Disease Biomarkers. Clin. Chem. 2013, 59, 903–916. DOI: 10.1373/clinchem.2013.202937.
   PubMed Web of Science ®Google Scholar
• Agnello, L.; Piccoli, T.; Vidali, M.; Cuffaro, L.; Lo Sasso, B.; Iacolino, G.; Giglio, V. R.; Lupo, F.; Alongi, P.; Bivona, G.; Ciaccio, M. Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers Measured by Chemiluminescent Enzyme Immunoassay for Alzheimer Disease Diagnosis. Scand. J. Clin. Lab. Invest. 2020, 80, 313–315. DOI: 10.1080/00365513.2020.1740939.
   PubMed Web of Science ®Google Scholar
• Andreasson, U.; Blennow, K.; Zetterberg, H. Update on Ultrasensitive Technologies to Facilitate Research on Blood Biomarkers for Central Nervous System Disorders. Alzheimers Dement. (Amst.) 2016, 3, 98–102. DOI: 10.1016/j.dadm.2016.05.005.
   PubMedGoogle Scholar
• Ghanbari, H. A.; Ghanbari, H. A.; Kozuk, T.; Miller, B. E.; Riesing, S. A Sandwich Enzyme Immunoassay for Detecting and Measuring Alzheimer’s Disease-Associated Proteins in Human Brain Tissue . J. Clin. Lab. Anal. 1990, 4, 189–192. DOI: 10.1002/jcla.1860040308.
   PubMed Web of Science ®Google Scholar
• Mascini, M.; Tombelli, S. Biosensors for Biomarkers in Medical Diagnostics. Biomarkers 2008, 13, 637–657. DOI: 10.1080/13547500802645905.
   PubMed Web of Science ®Google Scholar
• Jason‐Moller, L.; Murphy, M.; Bruno, J. Overview of Biacore Systems and Their Applications. Curr. Protocols Protein Sci. 2006, 45, 19.13.1–19.13.14. DOI: 10.1002/0471140864.ps1913s45.
   Google Scholar
• PubMed.gov, National Library of Medicine. 2020. https://pubmed.ncbi.nlm.nih.gov/?term=surface+plasmon+resonance&filter=simsearch1.fha.
   Google Scholar
• Vasić, B.; Isić, G.; Gajić, R. Localized Surface Plasmon Resonances in Graphene Ribbon Arrays for Sensing of Dielectric Environment at Infrared Frequencies. J. Appl. Phys. 2013, 113, 013110. DOI: 10.1063/1.4773474.
   Web of Science ®Google Scholar
• Rich, R. L.; Myszka, D. G. Advances in Surface Plasmon Resonance Biosensor Analysis. Curr. Opin. Biotechnol. 2000, 11, 54–61. DOI: 10.1016/S0958-1669(99)00054-3.
   PubMed Web of Science ®Google Scholar
• Nangare, S.; Patil, P. Affinity-Based Nanoarchitectured Biotransducer for Sensitivity Enhancement of Surface Plasmon Resonance Sensors for in Vitro Diagnosis: A Review. ACS Biomater. Sci. Eng. 2020. DOI: 10.1021/acsbiomaterials.0c01203.
   PubMed Web of Science ®Google Scholar
• Homola, J. Present and Future of Surface Plasmon Resonance Biosensors. Anal. Bioanal. Chem. 2003, 377, 528–539. DOI: 10.1007/s00216-003-2101-0.
   PubMed Web of Science ®Google Scholar
• Bellassai, N.; D'agata, R.; Jungbluth, V.; Spoto, G. Surface Plasmon Resonance for Biomarker Detection: Advances in Non-Invasive Cancer Diagnosis. Front. Chem. 2019, 7, 570. DOI: 10.3389/fchem.2019.00570.
   PubMed Web of Science ®Google Scholar
• Morales, M. A.; Halpern, J. M. Guide to Selecting a Biorecognition Element for Biosensors. Bioconjug. Chem. 2018, 29, 3231–3239. DOI: 10.1021/acs.bioconjchem.8b00592.
   PubMed Web of Science ®Google Scholar
• Nguyen, H. H.; Lee, S. H.; Lee, U. J.; Fermin, C. D.; Kim, M. Immobilized Enzymes in Biosensor Applications. Materials 2019, 12, 121. DOI: 10.3390/ma12010121.
   PubMed Web of Science ®Google Scholar
• Schroeder, H. W., Jr.; Cavacini, L. Structure and Function of Immunoglobulins. J. Allergy Clin. Immunol. 2010, 125, S41–S52. DOI: 10.1016/j.jaci.2009.09.046.
   PubMed Web of Science ®Google Scholar
• Lim, S. A.; Ahmed, M. U. Introduction to Immunosensors. In Immunosensors. London, UK: InTechOpen, 2019, pp. 1–20.
   Google Scholar
• Florea, A. S. Electrochemical Affinity Sensors for Biomedical, Food and Environmental Applications, 2015.
   Google Scholar
• Sela-Culang, I.; Kunik, V.; Ofran, Y. The Structural Basis of Antibody-Antigen Recognition. Front. Immunol. 2013, 4, 302. DOI: 10.3389/fimmu.2013.00302.
   PubMed Web of Science ®Google Scholar
• Dondelinger, M.; Filée, P.; Sauvage, E.; Quinting, B.; Muyldermans, S.; Galleni, M.; Vandevenne, M. S. Understanding the Significance and Implications of Antibody Numbering and Antigen-Binding Surface/Residue Definition . Front. Immunol. 2018, 9, 2278. DOI: 10.3389/fimmu.2018.02278.
   PubMed Web of Science ®Google Scholar
• Muyldermans, S. Single Domain Camel Antibodies: Current Status. J. Biotechnol. 2001, 74, 277–302. DOI: 10.1016/s1389-0352(01)00021-6.
   PubMed Web of Science ®Google Scholar
• Janeway, C. A.; Jr, Travers, P.; Walport, M.; Shlomchik, M. J. The Interaction of the Antibody Molecule with Specific Antigen. In Immunobiology: The Immune System in Health and Disease. 5th ed. New York, NY: Garland Science, 2001.
   Google Scholar
• Ronkainen, N. J.; Halsall, H. B.; Heineman, W. R. Electrochemical Biosensors. Chem. Soc. Rev. 2010, 39, 1747–1763. DOI: 10.1039/b714449k.
   PubMed Web of Science ®Google Scholar
• Hock, B. Antibodies for Immunosensors a Review. Anal. Chim. Acta 1997, 347, 177–186. DOI: 10.1016/S0003-2670(97)00167-0.
   Web of Science ®Google Scholar
• Li, F.; Vijayasankaran, N.; Shen, A.; Kiss, R.; Amanullah, A. Cell Culture Processes for Monoclonal Antibody Production. MAbs 2010, 2, 466–479. DOI: 10.4161/mabs.2.5.12720.
   PubMed Web of Science ®Google Scholar
• Nguyen, H. H.; Park, J.; Kang, S.; Kim, M. Surface Plasmon Resonance: A Versatile Technique for Biosensor Applications. Sensors (Basel) 2015, 15, 10481–10510. DOI: 10.3390/s150510481.
   PubMed Web of Science ®Google Scholar
• Shakesheff, K.; Tsourpas, G. Surface Modification to Tailor the Biological Response. In Tissue Engineering Using Ceramics and Polymers. New York, NY: Elsevier, 2007, pp. 108–128.
   Google Scholar
• Rahimi, F. Stammers Selected for Recognizing Amyloid β-Protein—A Case for Cautious Optimism. IJMS 2018, 19, 668. DOI: 10.3390/ijms19030668.
   Google Scholar
• Lakhin, A.; Tarantul, V.; Gening, L. Aptamers: problems, Solutions and Prospects. Acta Naturae. 2013, 5, 34–43. DOI: 10.32607/20758251-2013-5-4-34-43.
   PubMed Web of Science ®Google Scholar
• Ling, Z.; Ming-Hua, W.; Jian-Ping, W.; Zhun-Zhong, Y. Application of Biosensor Surface Immobilization Methods for Aptamer. Chin. J. Anal. Chem. 2011, 39, 432–438.
   Web of Science ®Google Scholar
• Liu, H.; Ge, J.; Ma, E.; Yang, L. Advanced Biomaterials for Biosensor and Theranostics. Biomater. Transl. Med. 2019, 2019, 213–255.
   Google Scholar
• Li, C.-Z.; Karadeniz, H.; Canavar, E.; Erdem, A. Electrochemical Sensing of Label Free DNA Hybridization Related to Breast Cancer 1 Gene at Disposable Sensor Platforms Modified with Single Walled Carbon Nanotubes. Electrochim. Acta 2012, 82, 137–142. DOI: 10.1016/j.electacta.2012.05.057.
   Web of Science ®Google Scholar
• Cieplak, M.; Kutner, W. Artificial Biosensors: how Can Molecular Imprinting Mimic Biorecognition? Trends Biotechnol. 2016, 34, 922–941. DOI: 10.1016/j.tibtech.2016.05.011.
   PubMed Web of Science ®Google Scholar
• Wackerlig, J.; Schirhagl, R. Applications of Molecularly Imprinted Polymer Nanoparticles and Their Advances toward Industrial Use: A Review. Anal. Chem. 2016, 88, 250–261. DOI: 10.1021/acs.analchem.5b03804.
   PubMed Web of Science ®Google Scholar
• Farka, Z.; Juřík, T.; Kovář, D.; Trnková, L.; Skládal, P. Nanoparticle-Based Immunochemical Biosensors and Assays: recent Advances and Challenges. Chem. Rev. 2017, 117, 9973–10042. DOI: 10.1021/acs.chemrev.7b00037.
   PubMed Web of Science ®Google Scholar
• Zarei, M. Portable Biosensing Devices for Point-of-Care Diagnostics: Recent Developments and Applications. TrAC - Trends Anal. Chem. 2017, 91, 26–41. DOI: 10.1016/j.trac.2017.04.001.
   Web of Science ®Google Scholar
• Katz, E.; Willner, I. Integrated Nanoparticle-Biomolecule Hybrid Systems: Synthesis, Properties, and Applications. Angew. Chem. Int. Ed. Engl. 2004, 43, 6042–6108. DOI: 10.1002/anie.200400651.
   PubMed Web of Science ®Google Scholar
• Omidfar, K.; Khorsand, F.; Azizi, M. D. New Analytical Applications of Gold Nanoparticles as Label in Antibody Based Sensors. Biosens. Bioelectron. 2013, 43, 336–347. DOI: 10.1016/j.bios.2012.12.045.
   PubMed Web of Science ®Google Scholar
• Tade, R. S.; Nangare, S. N.; Patil, P. O. Green Synthesis of Silver Nanoparticles: An Ecofriendly Approach. Nano Biomed. Eng. 2020, 12, 281–296. DOI: 10.5101/nbe.v12i1.p57-66.
   Google Scholar
• Jain, P. K.; Huang, X.; El-Sayed, I. H.; El-Sayed, M. A. Noble Metals on the Nanoscale: optical and Photothermal Properties and Some Applications in Imaging, Sensing, Biology, and Medicine. Acc. Chem. Res. 2008, 41, 1578–1586. DOI: 10.1021/ar7002804.
   PubMed Web of Science ®Google Scholar
• Holzinger, M.; Le Goff, A.; Cosnier, S. Nanomaterials for Biosensing Applications: A Review. Front. Chem. 2014, 2, 63. DOI: 10.3389/fchem.2014.00063.
   PubMed Web of Science ®Google Scholar
• Yang, C.; Denno, M. E.; Pyakurel, P.; Venton, B. J. Recent Trends in Carbon Nanomaterial-Based Electrochemical Sensors for Biomolecules: A Review. Anal. Chim. Acta. 2015, 887, 17–37. DOI: 10.1016/j.aca.2015.05.049.
   PubMed Web of Science ®Google Scholar
• Maduraiveeran, G.; Sasidharan, M.; Ganesan, V. Electrochemical Sensor and Biosensor Platforms Based on Advanced Nanomaterials for Biological and Biomedical Applications. Biosens. Bioelectron. 2018, 103, 113–129. DOI: 10.1016/j.bios.2017.12.031.
   PubMed Web of Science ®Google Scholar
• Giljohann, D. A.; Mirkin, C. A. Drivers of Biodiagnostic Development. Nature 2009, 462, 461–464. DOI: 10.1038/nature08605.
   PubMed Web of Science ®Google Scholar
• Kalia, J.; Raines, R. T. Advances in Bioconjugation. Curr. Org. Chem. 2010, 14, 138–147. DOI: 10.2174/138527210790069839.
   PubMed Web of Science ®Google Scholar
• Gómez-Arribas, L. N.; Benito-Peña, E.; Hurtado-Sánchez, M. D. C.; Moreno-Bondi, M. C. Biosensing Based on Nanoparticles for Food Allergens Detection. Sensors 2018, 18, 1087. DOI: 10.3390/s18041087.
   PubMed Web of Science ®Google Scholar
• Deshmukh, S.; Patil, S.; Mullani, S.; Delekar, S. Silver Nanoparticles as an Effective Disinfectant: A Review. Mater. Sci. Eng. C. Mater. Biol. Appl. 2019, 97, 954–965. DOI: 10.1016/j.msec.2018.12.102.
   PubMed Web of Science ®Google Scholar
• Olson, J.; Dominguez-Medina, S.; Hoggard, A.; Wang, L.-Y.; Chang, W.-S.; Link, S. Optical Characterization of Single Plasmonic Nanoparticles. Chem. Soc. Rev. 2015, 44, 40–57. DOI: 10.1039/c4cs00131a.
   PubMed Web of Science ®Google Scholar
• Kairdolf, B. A.; Smith, A. M.; Stokes, T. H.; Wang, M. D.; Young, A. N.; Nie, S. Semiconductor Quantum Dots for Bioimaging and Biodiagnostic Applications. Annu Rev Anal Chem (Palo Alto Calif) 2013, 6, 143–162. DOI: 10.1146/annurev-anchem-060908-155136.
   PubMed Web of Science ®Google Scholar
• Kairdolf, B. A.; Qian, X.; Nie, S. Bioconjugated Nanoparticles for Biosensing, in Vivo Imaging, and Medical Diagnostics. Anal. Chem. 2017, 89, 1015–1031. DOI: 10.1021/acs.analchem.6b04873.
   PubMed Web of Science ®Google Scholar
• Syedmoradi, L.; Daneshpour, M.; Alvandipour, M.; Gomez, F. A.; Hajghassem, H.; Omidfar, K. Point of Care Testing: The Impact of Nanotechnology. Biosens. Bioelectron. 2017, 87, 373–387. DOI: 10.1016/j.bios.2016.08.084.
   PubMed Web of Science ®Google Scholar
• Zhang, A.; Lieber, C. M. Nano-Bioelectronics. Chem. Rev. 2016, 116, 215–257. DOI: 10.1021/acs.chemrev.5b00608.
   PubMed Web of Science ®Google Scholar
• Hou, S.; Zhang, A.; Su, M. Nanomaterials for Biosensing Applications. Basel, Switzerland: Multidisciplinary Digital Publishing Institute, 2016.
   Google Scholar
• Stephanopoulos, N.; Francis, M. B. Choosing an Effective Protein Bioconjugation Strategy. Nat. Chem. Biol. 2011, 7, 876–884. DOI: 10.1038/nchembio.720.
   PubMed Web of Science ®Google Scholar
• Zhou, M.; Nakatani, E.; Gronenberg, L. S.; Tokimoto, T.; Wirth, M. J.; Hruby, V. J.; Roberts, A.; Lynch, R. M.; Ghosh, I. Peptide-Labeled Quantum Dots for Imaging GPCRs in Whole Cells and as Single Molecules. Bioconjug. Chem. 2007, 18, 323–332. DOI: 10.1021/bc0601929.
   PubMed Web of Science ®Google Scholar
• Lee, J.-H.; Kang, D.-Y.; Lee, T.; Kim, S.-U.; Oh, B.-K.; Choi, J.-W. Signal Enhancement of Surface Plasmon Resonance Based Immunosensor Using Gold Nanoparticle-Antibody Complex for Beta-Amyloid (1-40) Detection . J. Nanosci. Nanotechnol. 2009, 9, 7155–7160. DOI: 10.1166/jnn.2009.1613.
   PubMed Web of Science ®Google Scholar
• Ruiz, G.; Tripathi, K.; Okyem, S.; Driskell, J. D. pH Impacts the Orientation of Antibody Adsorbed onto Gold Nanoparticles. Bioconjug. Chem. 2019, 30, 1182–1191. DOI: 10.1021/acs.bioconjchem.9b00123.
   PubMed Web of Science ®Google Scholar
• Tripathi, K.; Driskell, J. D. Quantifying Bound and Active Antibodies Conjugated to Gold Nanoparticles: A Comprehensive and Robust Approach to Evaluate Immobilization Chemistry. ACS Omega. 2018, 3, 8253–8259. DOI: 10.1021/acsomega.8b00591.
   PubMed Web of Science ®Google Scholar
• Zhang, L. Design of Plasmonic Nanoparticles and Their Use for Biotoxin Immunosensing. Paris, France: Sorbonne Université, 2018.
   Google Scholar
• Kim, H.; Lee, J. U.; Song, S.; Kim, S.; Sim, S. J. A Shape-Code Nanoplasmonic Biosensor for Multiplex Detection of Alzheimer's Disease Biomarkers. Biosens. Bioelectron. 2018, 101, 96–102. DOI: 10.1016/j.bios.2017.10.018.
   PubMed Web of Science ®Google Scholar
• Vestergaard, M. d.; Kerman, K.; Kim, D.-K.; Hiep, H. M.; Tamiya, E. Detection of Alzheimer's Tau Protein Using Localised Surface Plasmon Resonance-Based Immunochip. Talanta 2008, 74, 1038–1042. DOI: 10.1016/j.talanta.2007.06.009.
   PubMed Web of Science ®Google Scholar
• Nu, T. T. V.; Tran, N. H. T.; Nam, E.; Nguyen, T. T.; Yoon, W. J.; Cho, S.; Kim, J.; Chang, K.-A.; Ju, H. Blood-Based Immunoassay of Tau Proteins for Early Diagnosis of Alzheimer's Disease Using Surface Plasmon Resonance Fiber Sensors. RSC Adv. 2018, 8, 7855–7862. DOI: 10.1039/C7RA11637C.
   PubMed Web of Science ®Google Scholar
• Haes, A. J.; Chang, L.; Klein, W. L.; Van Duyne, R. P. Detection of a Biomarker for Alzheimer's Disease from Synthetic and Clinical Samples Using a Nanoscale Optical Biosensor. J. Am. Chem. Soc. 2005, 127, 2264–2271. DOI: 10.1021/ja044087q.
   PubMed Web of Science ®Google Scholar
• Kim, S.; Wark, A. W.; Lee, H. J. Femtomolar Detection of Tau Proteins in Undiluted Plasma Using Surface Plasmon Resonance. Anal. Chem. 2016, 88, 7793–7799. DOI: 10.1021/acs.analchem.6b01825.
   PubMed Web of Science ®Google Scholar
• Lee, Y. K.; Lee, K.-S.; Kim, W. M.; Sohn, Y.-S. Detection of Amyloid-β42 Using a Waveguide-Coupled Bimetallic Surface Plasmon Resonance Sensor Chip in the Intensity Measurement Mode. PLoS One. 2014, 9, e98992. DOI: 10.1371/journal.pone.0098992.
   PubMed Web of Science ®Google Scholar
• Yi, X.; Feng, C.; Hu, S.; Li, H.; Wang, J. Surface Plasmon Resonance Biosensors for Simultaneous Monitoring of Amyloid-Beta Oligomers and Fibrils and Screening of Select Modulators. Analyst 2016, 141, 331–336. DOI: 10.1039/c5an01864a.
   PubMed Web of Science ®Google Scholar
• Palladino, P.; Aura, A. M.; Spoto, G. Surface Plasmon Resonance for the label-free detection of Alzheimer's β-Amyloid Peptide Aggregation . Anal. Bioanal. Chem. 2016, 408, 849–854. DOI: 10.1007/s00216-015-9172-6.
   PubMed Web of Science ®Google Scholar
• Poduslo, J. F.; Ramakrishnan, M.; Wengenack, T. M.; Kandimalla, K. K.; Howell, K. G. Surface Plasmon Resonance Binding Kinetics of Alzheimer's Disease Amyloid β Peptide Capturing-and Plaque Binding-Monoclonal Antibodies. Alzheimer Dement. 2010, 6, S535–S536. DOI: 10.1016/j.jalz.2010.05.1787.
   Google Scholar
• Kim, H. J.; Sohn, Y.-S.; Kim, C-d.; Jang, D-h. Surface Plasmon Resonance Sensing of a Biomarker of Alzheimer Disease in an Intensity Measurement Mode with a Bimetallic Chip. J. Korean Phys. Soc. 2016, 69, 793–797. DOI: 10.3938/jkps.69.793.
   Web of Science ®Google Scholar
• Špringer, T.; Hemmerová, E.; Finocchiaro, G.; Krištofiková, Z.; Vyhnálek, M.; Homola, J. Surface Plasmon Resonance Biosensor for the Detection of Tau-Amyloid β Complex. Sens. Actuators, B. 2020, 316, 128146. DOI: 10.1016/j.snb.2020.128146.
   Web of Science ®Google Scholar
• Xia, N.; Liu, L.; Harrington, M. G.; Wang, J.; Zhou, F. Regenerable and Simultaneous Surface Plasmon Resonance Detection of aβ(1-40) and aβ(1-42) Peptides in Cerebrospinal Fluids with Signal Amplification by Streptavidin Conjugated to an N-Terminus-Specific Antibody . Anal. Chem. 2010, 82, 10151–10157. DOI: 10.1021/ac102257m.
   PubMed Web of Science ®Google Scholar
• O'Brien, R. J.; Wong, P. C. Amyloid Precursor Protein Processing and Alzheimer's Disease. Annu. Rev. Neurosci. 2011, 34, 185–204. DOI: 10.1146/annurev-neuro-061010-113613.
   PubMed Web of Science ®Google Scholar
• Viola, K.; Velasco, P.; Klein, W. L. Why Alzheimer’s is a Disease of Memory: The Attack on Synapses by Aß Oligomers (ADDLs). J. Nutr. Health Aging 2008, 12, S51–S57. DOI: 10.1007/BF02982587.
   Web of Science ®Google Scholar
• Zhu, S.; Du, C.; Fu, Y.; Deng, Q.; Shi, L. Influence of Cr Adhesion Layer on Detection of Amyloid-Derived Diffusible Ligands Based on Localized Surface Plasmon Resonance. Plasmonics 2009, 4, 135–140. DOI: 10.1007/s11468-009-9084-4.
   Web of Science ®Google Scholar
• Ramakrishnan, M.; Kandimalla, K. K.; Wengenack, T. M.; Howell, K. G.; Poduslo, J. F. Surface Plasmon Resonance Binding Kinetics of Alzheimer’s Disease Amyloid Beta Peptide-Capturing and Plaque-Binding Monoclonal Antibodies . Biochemistry 2009, 48, 10405–10415. DOI: 10.1021/bi900523q.
   PubMed Web of Science ®Google Scholar
• Zayats, M.; Pogorelova, S. P.; Kharitonov, A. B.; Lioubashevski, O.; Katz, E.; Willner, I. Au Nanoparticle-Enhanced Surface Plasmon Resonance Sensing of Biocatalytic Transformations. Chemistry 2003, 9, 6108–6114. DOI: 10.1002/chem.200305104.
   PubMed Web of Science ®Google Scholar
• Zhao, Z.; Zhu, L.; Bu, X.; Ma, H.; Yang, S.; Yang, Y.; Hu, Z. Label-Free Detection of Alzheimer’s Disease through the ADP3 Peptoid Recognizing the Serum Amyloid-beta42 Peptide . Chem. Commun. (Camb.) 2015, 51, 718–721. DOI: 10.1039/c4cc07037b.
   PubMed Web of Science ®Google Scholar
• Weingarten, M. D.; Lockwood, A. H.; Hwo, S.-Y.; Kirschner, M. W. A Protein Factor Essential for Microtubule Assembly. Proc. Natl. Acad. Sci. U. S. A. 1975, 72, 1858–1862. DOI: 10.1073/pnas.72.5.1858.
   PubMed Web of Science ®Google Scholar
• Mietelska-Porowska, A.; Wasik, U.; Goras, M.; Filipek, A.; Niewiadomska, G. Tau Protein Modifications and Interactions: their Role in Function and Dysfunction. Int. J. Mol. Sci. 2014, 15, 4671–4713. DOI: 10.3390/ijms15034671.
   PubMed Web of Science ®Google Scholar
• Watanabe, A.; Hasegawa, M.; Suzuki, M.; Takio, K.; Morishima-Kawashima, M.; Titani, K.; Arai, T.; Kosik, K.; Ihara, Y. In Vivo Phosphorylation Sites in Fetal and Adult Rat Tau. J. Biol. Chem. 1993, 268, 25712–25717.
   PubMed Web of Science ®Google Scholar
• Shekhar, S.; Kumar, R.; Rai, N.; Kumar, V.; Singh, K.; Upadhyay, A. D.; Tripathi, M.; Dwivedi, S.; Dey, A. B.; Dey, S. Estimation of Tau and Phosphorylated tau181 in Serum of Alzheimer’s Disease and Mild Cognitive Impairment Patients. PLoS One 2016, 11, e0159099. DOI: 10.1371/journal.pone.0159099.
   PubMed Web of Science ®Google Scholar
• Lisi, S.; Scarano, S.; Fedeli, S.; Pascale, E.; Cicchi, S.; Ravelet, C.; Peyrin, E.; Minunni, M. Toward Sensitive Immuno-Based Detection of Tau Protein by Surface Plasmon Resonance Coupled to Carbon Nanostructures as Signal Amplifiers. Biosens. Bioelectron. 2017, 93, 289–292. DOI: 10.1016/j.bios.2016.08.078.
   PubMed Web of Science ®Google Scholar
• Sciacca, B.; François, A.; Klingler-Hoffmann, M.; Brazzatti, J.; Penno, M.; Hoffmann, P.; Monro, T. M. Radiative-Surface Plasmon Resonance for the Detection of Apolipoprotein E in Medical Diagnostics Applications. Nanomedicine 2013, 9, 550–557. DOI: 10.1016/j.nano.2012.10.007.
   PubMed Web of Science ®Google Scholar
• Yi, X.; Xia, Y.; Ding, B.; Wu, L.; Hu, S.; Wang, Z.; Yang, M.; Wang, J. Dual-Channel Surface Plasmon Resonance for Quantification of ApoE Gene and Genotype Discrimination in Unamplified Genomic DNA Extracts. ACS Sens. 2018, 3, 2402–2407. DOI: 10.1021/acssensors.8b00845.
   PubMed Web of Science ®Google Scholar
• Kant, R.; Gupta, B. D. Fiber-Optic SPR Based Acetylcholine Biosensor Using Enzyme Functionalized Ta 2 O 5 Nanoflakes for Alzheimer's Disease Diagnosis. J. Lightwave Technol. 2018, 36, 4018–4024. DOI: 10.1109/JLT.2018.2856924.
   Web of Science ®Google Scholar
• Hegnerová, K.; Bockova, M.; Vaisocherová, H.; Krištofiková, Z.; Říčný, J.; Řípová, D.; Homola, J. Surface Plasmon Resonance Biosensors for Detection of Alzheimer Disease Biomarker. Sens. Actuators, B. 2009, 139, 69–73. DOI: 10.1016/j.snb.2008.09.006.
   Web of Science ®Google Scholar
• Trushina, E.; Mielke, M. M. Recent Advances in the Application of Metabolomics to Alzheimer's Disease. Biochim. Biophys. Acta. 2014, 1842, 1232–1239. DOI: 10.1016/j.bbadis.2013.06.014.
   PubMed Web of Science ®Google Scholar
• Wilkins, J. M.; Trushina, E. Application of Metabolomics in Alzheimer’s Disease. Front. Neurol. 2017, 8, 719. DOI: 10.3389/fneur.2017.00719.
   PubMed Web of Science ®Google Scholar
• Paglia, G.; Stocchero, M.; Cacciatore, S.; Lai, S.; Angel, P.; Alam, M. T.; Keller, M.; Ralser, M.; Astarita, G. Unbiased Metabolomic Investigation of Alzheimer’s Disease Brain Points to Dysregulation of Mitochondrial Aspartate Metabolism. J. Proteome Res. 2016, 15, 608–618. DOI: 10.1021/acs.jproteome.5b01020.
   PubMed Web of Science ®Google Scholar